STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] CHARLES & COLVARD LTD SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

Riverstyx-affiliated holders report beneficial ownership of 232,106 shares, representing 7.4% of Charles & Colvard Ltd. The filing states that the Riverstyx Fund, LP submitted a notice nominating three individuals—Ben Franklin, Michael R. Levin, and Lloyd M. Sems—for election to the issuer's board and that the nominees' consents are filed as an exhibit. The reporting entities include Riverstyx Capital Management LLC, The Riverstyx Fund, LP, Riverstyx Fund, GP and Ben Franklin, each disclosing shared voting and dispositive power over the reported position.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: A 7.4% stake plus board nominations is a material investor action that could affect governance and shareholder dynamics.

The filing discloses a 7.4% beneficial position held in aggregate by Riverstyx-related entities and identifies a formal nomination of three directors. From a capital markets perspective, a disclosed stake of this size combined with director nominations is a notable governance engagement; it may prompt investor and management attention given the potential to influence board composition. The filing itself provides ownership details and the names of nominees but does not include any broader strategic proposals, transaction terms, or planned changes to corporate strategy or operations.

TL;DR: Nomination of three directors alongside a 7.4% position is a substantive governance event requiring issuer response and shareholder consideration.

The disclosure confirms that Riverstyx Fund, LP formally nominated three individuals and that the nominees' consents are attached as an exhibit. This is a clear, actionable governance step under SEC rules: nominative filings typically initiate dialogue between nominating holders, the board, and other shareholders. The record shows shared voting and dispositive power reported across related entities and an aggregate ownership figure, but it does not describe any agreements, support arrangements, or solicitation plans; those would be material if they exist and are not included here.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Riverstyx Capital Management LLC
Signature:Ben Franklin
Name/Title:Manager of its GP
Date:08/25/2025
The Riverstyx Fund, LP
Signature:Ben Franklin
Name/Title:Manager
Date:08/25/2025
Riverstyx Fund, GP
Signature:Ben Franklin
Name/Title:Manager
Date:08/25/2025
Ben Franklin
Signature:Ben Franklin
Name/Title:Ben Franklin
Date:08/25/2025

FAQ

How many shares does Riverstyx report owning in Charles & Colvard (CTHR)?

The filing discloses an aggregate beneficial ownership of 232,106 shares.

What percentage of Charles & Colvard does the reported position represent?

The reported position represents 7.4% of the company's common stock class.

Who were nominated for the board in this Schedule 13D/A?

The nominees named in the filing are Ben Franklin, Michael R. Levin, and Lloyd M. Sems.

Are the nominees' consents included with the filing?

Yes; the filing states that the nominees' consents are filed as Exhibit 1.

Which entities are listed as reporting persons on this filing?

Reporting persons include Riverstyx Capital Management LLC, The Riverstyx Fund, LP, Riverstyx Fund, GP, and Ben Franklin.

Does the filing describe any other plans or agreements related to the nomination?

No; the filing does not disclose any additional plans, agreements, or solicitation arrangements beyond the nomination and consents.
Charles & Colvard Ltd

OTC:CTHR

CTHR Rankings

CTHR Latest News

CTHR Latest SEC Filings

CTHR Stock Data

4.43M
1.14M
25.06%
0%
0.95%
Luxury Goods
Jewelry, Silverware & Plated Ware
Link
United States
MORRISVILLE